FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133609632> ?p ?o ?g. }

• W3133609632 endingPage "411" @default.
• W3133609632 startingPage "399" @default.
• W3133609632 abstract "NMDA receptors are ligand-gated ion channels that mediate a slow, Ca2+-permeable component of excitatory synaptic currents. These receptors are involved in several important brain functions, including learning and memory, and have also been implicated in neuropathological conditions and acute central nervous system injury, which has driven therapeutic interest in their modulation. The EU1794 series of positive and negative allosteric modulators of NMDA receptors has structural determinants of action near the preM1 helix that is involved in channel gating. Here, we describe the effects of the negative allosteric modulator EU1794-4 on GluN1/GluN2A channels studied in excised outside-out patches. Coapplication of EU1794-4 with a maximally effective concentration of glutamate and glycine increases the fraction of time the channel is open by nearly 1.5-fold, yet reduces single-channel conductance by increasing access of the channel to several subconductance levels, which has the net overall effect of reducing the macroscopic current. The lack of voltage-dependence of negative modulation suggests this is unrelated to a channel block mechanism. As seen with other NMDA receptor modulators that reduce channel conductance, EU1794-4 also reduces the Ca2+ permeability relative to monovalent cations of GluN1/GluN2A receptors. We conclude that EU1794-4 is a prototype for a new class of NMDA receptor negative allosteric modulators that reduce both the overall current that flows after receptor activation and the flux of Ca2+ ion relative to monovalent cations. SIGNIFICANCE STATEMENT: NMDA receptors are implicated in many neurological conditions but are challenging to target given their ubiquitous expression. Several newly identified properties of the negative allosteric modulator EU1794-4, including reducing Ca2+ flux through NMDA receptors and attenuating channel conductance, explain why this modulator reduces but does not eliminate NMDA receptor function. A modulator with these properties could have therapeutic advantages for indications in which attenuation of NMDA receptor function is beneficial, such as neurodegenerative disease and acute injury." @default.
• W3133609632 created "2021-03-15" @default.
• W3133609632 creator A5017947172 @default.
• W3133609632 creator A5032077625 @default.
• W3133609632 creator A5039466980 @default.
• W3133609632 creator A5040477247 @default.
• W3133609632 creator A5041161550 @default.
• W3133609632 creator A5055176739 @default.
• W3133609632 creator A5063201908 @default.
• W3133609632 creator A5069780485 @default.
• W3133609632 creator A5075559447 @default.
• W3133609632 creator A5084356258 @default.
• W3133609632 creator A5091825209 @default.
• W3133609632 date "2021-03-09" @default.
• W3133609632 modified "2023-10-12" @default.
• W3133609632 title "The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca²⁺ Permeability of GluN1/GluN2A <i>N</i>-Methyl-d-Aspartate Receptors" @default.
• W3133609632 cites W123308475 @default.
• W3133609632 cites W1482790727 @default.
• W3133609632 cites W1543054176 @default.
• W3133609632 cites W1758018633 @default.
• W3133609632 cites W178731299 @default.
• W3133609632 cites W1843854943 @default.
• W3133609632 cites W1968333334 @default.
• W3133609632 cites W1975583330 @default.
• W3133609632 cites W1975716246 @default.
• W3133609632 cites W1978710583 @default.
• W3133609632 cites W1980311878 @default.
• W3133609632 cites W1984804294 @default.
• W3133609632 cites W1995776925 @default.
• W3133609632 cites W1998758449 @default.
• W3133609632 cites W2001893348 @default.
• W3133609632 cites W2021358447 @default.
• W3133609632 cites W2024380057 @default.
• W3133609632 cites W2025606077 @default.
• W3133609632 cites W2026022416 @default.
• W3133609632 cites W2033678540 @default.
• W3133609632 cites W2035750459 @default.
• W3133609632 cites W2036968549 @default.
• W3133609632 cites W2037852973 @default.
• W3133609632 cites W2041204070 @default.
• W3133609632 cites W2043814101 @default.
• W3133609632 cites W2053442326 @default.
• W3133609632 cites W2065110684 @default.
• W3133609632 cites W2065169750 @default.
• W3133609632 cites W2070064704 @default.
• W3133609632 cites W2070139095 @default.
• W3133609632 cites W2075970098 @default.
• W3133609632 cites W2076256595 @default.
• W3133609632 cites W2083004303 @default.
• W3133609632 cites W2085402579 @default.
• W3133609632 cites W2086337747 @default.
• W3133609632 cites W2092981265 @default.
• W3133609632 cites W2093159949 @default.
• W3133609632 cites W2099110968 @default.
• W3133609632 cites W2104147494 @default.
• W3133609632 cites W2108909652 @default.
• W3133609632 cites W2109708478 @default.
• W3133609632 cites W2123152434 @default.
• W3133609632 cites W2123636141 @default.
• W3133609632 cites W2131673806 @default.
• W3133609632 cites W2135781323 @default.
• W3133609632 cites W2136796082 @default.
• W3133609632 cites W2139654564 @default.
• W3133609632 cites W2139748951 @default.
• W3133609632 cites W2147045345 @default.
• W3133609632 cites W2151199745 @default.
• W3133609632 cites W2153146722 @default.
• W3133609632 cites W2153775014 @default.
• W3133609632 cites W2164254780 @default.
• W3133609632 cites W2164370979 @default.
• W3133609632 cites W2175972728 @default.
• W3133609632 cites W2342092395 @default.
• W3133609632 cites W2552904983 @default.
• W3133609632 cites W2778382764 @default.
• W3133609632 cites W2784635559 @default.
• W3133609632 cites W2789119671 @default.
• W3133609632 cites W2804965397 @default.
• W3133609632 cites W2890312008 @default.
• W3133609632 cites W2891947782 @default.
• W3133609632 cites W2969618849 @default.
• W3133609632 cites W2999911279 @default.
• W3133609632 cites W3014932431 @default.
• W3133609632 cites W3015274794 @default.
• W3133609632 cites W3015896371 @default.
• W3133609632 cites W3020387832 @default.
• W3133609632 cites W3046329739 @default.
• W3133609632 cites W3087258554 @default.
• W3133609632 cites W3109735706 @default.
• W3133609632 cites W3112042862 @default.
• W3133609632 doi "https://doi.org/10.1124/molpharm.120.000218" @default.
• W3133609632 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8058507" @default.
• W3133609632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33688039" @default.
• W3133609632 hasPublicationYear "2021" @default.
• W3133609632 type Work @default.
• W3133609632 sameAs 3133609632 @default.
• W3133609632 citedByCount "6" @default.
• W3133609632 countsByYear W31336096322021 @default.
• W3133609632 countsByYear W31336096322023 @default.

• next